Chris Tuell Ed.D., LPCC-S, LICDC-CS
Clinical Director of Addiction Services Lindner Center of HOPE
Assistant Professor, Department of Psychiatry & Behavioral Neuroscience University of Cincinnati College of Medicine

In 1987, Francine Shapiro went for a walk. While on her walk, Francine was contemplating some very upsetting personal events that were occurring in her life at the time. But as she began to focus on this upsetting information, she noticed that her eyes began to flicker from side to side. More importantly, she noticed that the once upsetting information was no longer as upsetting. Shapiro felt that she had stumbled on some aspect of how the mind processes information. Eye Movement Desensitization and Reprocessing, better known as EMDR, was born.

For the past 30 years EMDR has become one of the most effective therapeutic approaches in the treatment of trauma. EMDR is not only approved by the American Psychiatric and Psychological Associations, but also by the United States Department of Defense and the Veterans Administration, as an effective therapy in the treatment of post traumatic stress disorder (PTSD). Dr. Shapiro believes that one of the major theories behind EMDR is the bilateral stimulation of both hemispheres of the brain. When we sleep at night, our brain continues to process information. This occurs during rapid eye movement sleep or better known as REM sleep.

The brain processes the events of the day, keeping what is important (e.g. family, work, school, friends), and purging what is unimportant (e.g., What I had for dinner last Tuesday). How many times have we have been faced with a tough decision and resorted to, “I’ll just sleep on it,” only to awake the next morning with a better idea of what to do? But when a traumatic event occurs, the processing of this information becomes disrupted. The brain becomes unable to process and clear the event or information, resulting in the trauma experience continuing to occur as if it is happening all over again. In this playing-out, the right hemisphere of the brain, the part of our brain that experiences emotions such as fear and anxiety, continues to be activated by the unresolved trauma. The patient experiences this activation through intrusive thoughts, flashbacks, and disturbing dreams, the basic elements of PTSD.

EMDR involves the bilateral stimulation of both hemispheres of the brain while targeting the upsetting aspects of the trauma. In therapy, the therapist recreates what happens naturally during REM sleep, with the movement of the eyes as they follow the therapist’s hand, stimulating both hemispheres of the brain. Over the years, additional bilateral stimulation methods have been found to be effective (i.e., tactile, audio). This targeting involves, not only activating the image of the event, but also identifying the negative thoughts, emotions and sensations experienced by the patient from the trauma. During the reprocessing of the trauma experience, the logical, rational part of the brain, the left hemisphere, is integrated with the right emotional hemisphere. This results in the patient having a more adaptive response to the trauma. The patient may still have memory of the event, but the emotional aspects of fear and anxiety have dissipated. During EMDR, the left hemisphere of the brain, the rational, logical part, is integrated with the emotional right hemisphere of the brain, resulting in the patient feeling and knowing that, “The trauma is no longer happening to me now; The trauma is in the past; I am safe now.”

EMDR is not a wonder cure nor is it a quick fix. EMDR involves hard work by the patient and it takes a good amount of clinical skills in order to implement. This is not about touching the person’s forehead and he or she is better. The patient and therapist have to be responsible and work at this process, but it does appear to go much more rapidly than traditional types of therapy. If a trauma can occur within a few moments, why do we automatically accept that it has to take years to undo it?

More than 20,000 practitioners have been trained to use EMDR since its discovery. The use of EMDR has been found to be beneficial in other areas of mental health besides, PTSD. Areas such as panic disorders, anxiety disorders, grief, pain, stress, addiction, and abuse, have shown to be responsive to this unique therapy. One aspect of EMDR that I have found to be valuable is the fact that it is unnecessary for me, as the clinician, to know all the details and specifics of a patient’s trauma in order for EMDR to be helpful. Many individuals who have experienced trauma stay clear of therapy for fear of reliving the memories and feelings. The EMDR protocol allows for such traumatic episodes to be addressed and reprocessed without describing the details of the trauma. As a practitioner, I have found EMDR to be a valuable therapeutic tool in assisting patients in moving past one’s past.

For more information about EMDR: https://www.emdria.org

 

 

By Danielle J. Johnson, MD, FAPA
Lindner Center of HOPE, Chief of Adult Psychiatry

May is Maternal Mental Health Awareness Month.  One in five women will develop a maternal mental health disorder.  They are also referred to as perinatal mood and anxiety disorders (PMADs) to emphasize that women experience more than postpartum depression during pregnancy and after birth.  Women who have symptoms of PMADs might not seek help because of guilt, shame, or embarrassment for feeling something different than the expected norms of motherhood.  Awareness and education are important to reduce stigma so mothers and babies get the help they need.

PMADs can occur during pregnancy or up to one year after giving birth. The most common PMAD is the “baby blues”, affecting up to 80% of new mothers.  Symptoms include sudden mood swings, loneliness, sadness, crying spells, loss of appetite, problems sleeping, irritability, restlessness, and anxiety.  These symptoms are a normal adjustment to changes in hormones and resolve without treatment in two to three weeks.

About 10% of women experience depression during pregnancy and about 15% during the first year postpartum.  Feeling sad, hopeless, helpless, or worthless; fatigue, difficulty sleeping or sleeping too much, appetite changes, difficulty concentrating, crying, loss of interest or pleasure; lack of interest in, difficulty bonding with, or excessive anxiety about the baby; feelings of being a bad mother, and fear of harming the baby or self are symptoms of peripartum depression.  Risk factors include poverty, being a teen mother, advanced maternal age; personal or family history of depression, anxiety, or postpartum depression; premenstrual dysphoric disorder, inadequate support, financial stress, relationship stress; complications in pregnancy, birth or breastfeeding; a history of abuse or trauma, a major recent life event, birth of multiples, babies in neonatal intensive care, infertility treatments, thyroid imbalance, and diabetes.

Anxiety can occur alone, or with depression, in 10% of new mothers.  Symptoms include constant worry, racing thoughts, inability to sit still, changes in sleep or appetite, feeling that something bad is going to happen; and physical symptoms like dizziness, hot flashes, and nausea.  Some mothers may also have panic attacks with shortness of breath, chest pain, dizziness, a feeling of losing control, and numbness and tingling.  Risk factors are a personal or family history of anxiety, previous perinatal depression or anxiety, and thyroid imbalance.

Post-traumatic stress disorder (PTSD) can occur in up to 6% of mothers following a traumatic childbirth.  Possible traumas are prolapsed cord, unplanned C-section, use of vacuum extractor or forceps to deliver the baby, baby going to NICU; and feelings of powerlessness, poor communication and/or lack of support and reassurance during the delivery.  Women who have experienced a previous sexual trauma are also at a higher risk for developing postpartum PTSD.  Intrusive re-experiencing of the traumatic event, flashbacks or nightmares; avoidance of stimuli associated with the event; increased arousal (irritability, difficulty sleeping, hypervigilance, exaggerated startle response); anxiety and panic attacks, and feeling a sense of unreality and detachment are symptoms of PTSD.

Obsessive-compulsive disorder (OCD) can occur in 3% to 5% of new mothers.  Obsessions are persistent, repetitive thoughts or mental images, often related to the baby. Obsessions can be so bizarre or disturbing that they can be mistaken as psychosis.  Compulsions are repetitive acts performed to reduce obsessions.   Mothers are distressed by the obsessions which can lead to a fear of being left alone with the baby or hypervigilance in protecting the baby.  Mothers with postpartum OCD know that their thoughts are out of the ordinary and are unlikely to ever act on them.

Postpartum psychosis is the most severe of the PMADs.  It is often associated with an episode of bipolar disorder. It is rare, occurring in 1 to 2 per 1000 women.  The onset is abrupt, within 48 to 72 hours and up to two weeks after delivery. This is a psychiatric emergency, requiring immediate treatment.  Mothers may experience hallucinations (hearing voices or seeing things) and/or delusions (believing things that aren’t true.)  If psychosis occurs as part of a bipolar manic episode, there might be additional symptoms such as irritability, hyperactivity, decreased need for or inability to sleep, paranoia and suspiciousness, rapid mood swings, difficulty communicating, and confusion or memory loss. Risk factors are a personal or family history of bipolar disorder or a psychotic disorder.  Most women with postpartum psychosis do not have violent delusions but there is an up to 5% rate of infanticide or suicide due to acting on delusions or having irrational judgement.

PMADs are the most common complication of pregnancy and childbirth.  They are treatable with psychotherapy and/or medication and early intervention provides relief for the mother and ensures the baby’s wellbeing.

 

 

By Nicole Mori, RN, MSN, APRN-BC, Research Advanced Practice Nurse

The use of dietary supplements or vitamins for the treatment of depressive symptoms is increasingly common among patients. Factors driving this trend include unsatisfactory response with standard treatments, adverse drug events, skepticism about psychiatric medications and the perception of dietary supplements as “natural” and safe.

Although evidence increasingly supports the relationship between quality of diet and mood, more research is needed to clarify the role of dietary supplements in the management of depression. Consumers often take supplements based on inconclusive data from small, methodologically-flawed studies. Unlike FDA-approved drugs, supplements do not have to demonstrate unequivocal evidence for efficacy or safety. Adulteration, contamination, variations in potency, and product instability are not uncommon. When treating depressed patients, it is important to ask about use of dietary supplements and to be ready to offer guidance regarding the evidence for potential benefits, possible risks and drug-supplement interactions. The following are commonly-used supplements with a potential effect on depressive symptoms.

Omega 3 polyunsaturated fatty acids: Eicosapentanoic acid (EPA) and Docosahexaenoic acid (DHA)

Omega 3 fatty acids are long chain lipids found in oily fish. High dietary intake has been associated with low rates of depression. Omega 3 fatty acids enhance neurotransmission, neurogenesis and reduce inflammation. There is support for supplementation in Major depression with several meta-analyses showing efficacy. There is some evidence for efficacy of omega 3 fatty acids for bipolar depression. Over the counter products vary greatly in composition and EPA/DHA ratio. Evidence supports the use of EPA-dominant formulations. Adverse events and drug interactions are uncommon, but risk for excessive bleeding must be considered. Dose 1-2g of EPA/day.

Folic acid and Methylfolate

Involved in dopamine, serotonin and norepinephrine synthesis. Folate deficiency has been associated with increased risk for depression. Evidence supports adjunctive use of methylfolate with antidepressants for the reduction of Major depression symptoms. An FDA approved formulation of l-methylfolate available by prescription has shown efficacy at the 15mg/d dose level. Evidence for the efficacy of folic acid and Depression is mixed and there is no evidence supporting the use of either folate or methylfolate in Bipolar depression. Methylfolate is usually well-tolerated, although there are concerns about use masking B12 deficiency and historical concerns about cancer. Routine folate supplementation >1g/d is not recommended. l-methylfolate dosage is 7.5-30mg/day, maximum 1g/day (folate).

S-adenosylmethionine (SAMe)

An endogenous aminoacid involved in neurotransmitter synthesis. Decreased serum and CSF levels are associated with depression. A few studies support efficacy for supplementation in Major depression but more research is needed.  There is no data to support use of SAMe in bipolar depression. Adverse events include nausea and anxiety. May interact with serotonergic antidepressants and increase risk for manic and hypomanic episodes in Bipolar disorder. Dose 200-800 twice/day.

Vitamin D

Low serum concentrations have been associated with depression. Vitamin D acts as a receptor ligand in the prefrontal cortex and hypothalamus. Some evidence supports supplementation for reducing symptoms in clinically-depressed patients but further research is needed. Evidence does not support supplementation as a therapy for bipolar depression.  Caution regarding risk for hypercalcemia and toxicity with excessive intake. Dosing varies.

N-acetylcysteine (NAC)

Available as a nutritional supplement and as prescription medication for treating acetaminophen overdose. NAC has antioxidant and anti-inflammatory properties and modulates the glutamate pathway.  Some evidence for reduction in bipolar depression symptoms. Not effective in Major depression. Gastrointestinal upset may occur. Dosing 1-1.5g twice/day.

St. John’s Wort

A perennial herb containing active compound hypericin, which inhibits reuptake of dopamine, norepinephrine and serotonin. Some support for short-term efficacy in depressive symptoms, but more long term and safety data is needed. Significant risk for drug interactions due to interaction with serotonergic drugs (serotonin syndrome) and interference in the metabolism of hundreds of drugs by induction of Cytochrome P450 enzymes make this an undesirable adjunctive option. Dosing varies due to variability in potency.

Probiotics

Alterations in intestinal flora have been implicated in mood disorders, although the mechanism is unclear. Probiotic supplements are thought to impart a health benefit by optimizing intestinal flora and are used to manage gastrointestinal symptoms. Animal studies show blunting in inflammatory response and improvement in mood symptoms with supplementation, but few clinical trials yielded positive results. Products on the market vary in terms of bacterial strain content, stability and bioavailability. Adverse events are rare, except for opportunistic infection immunocompromised individuals. Dosing varies.

There isn’t a one size fits all or best supplement for depression. There are some benefits to adding in supplements for depression symptoms and in other areas more research is needed. Be sure to work with a medical professional and consider the potential benefits, possible risks and any drug-supplement interactions for medications you may already be taking.

If you are seeking help for your depressive symptoms, contact us at the Lindner Center of HOPE. There is HOPE.

 

References

Sarris J, Murphy J, Mischoulon D, et al. Adjunctive Nutraceuticals for Depression: A Systematic Review and Meta-Analyses. Am J Psychiatry. 2016;173(6):575-87. Nahas, R., & Sheikh, O. (2011).

Complementary and alternative medicine for the treatment of major depressive disorder. Canadian Family Physician57(6), 659–663.

Sarris J. Clinical use of nutraceuticals in the adjunctive treatment of depression in mood disorders. Australas Psychiatry. 2017;:1039856216689533.

Rakofsky JJ, Dunlop BW. Review of nutritional supplements for the treatment of bipolar depression. Depress Anxiety. 2014;31(5):379-90.

 

BY: Elizabeth Wassenaar, MS, MD, Lindner Center of HOPE, Staff Psychiatrist and Medical Director of Williams House

 

Life can be overwhelming and we all would like to take a day off every once in a while. Likely, as helping professionals, we don’t take mental health days as often as we could actually benefit from them.  This is one of the reasons why, when a child or adolescent refuses to go to school, we may be initially sympathetic.  Maybe a day or two off will help, we may think.  In too many cases, however, we see that a day or two off turns into something much more problematic as parents and professionals struggle to get a school avoider back to school.  Homework piles up, grades start to fall, and friends wonder what has happened to their classmate.  Parents try many different tactics to try to get their child back to school; bribing, negotiating, punishing, or even carrying a child through the school door.

Children want to not go to school for many reasonable causes: kids can be cruel; learning can be difficult; anxiety about performance can be overwhelming; health concerns can require special privileges that feel too identifying; and getting up early in the morning is harder for some more than others. Furthermore, mental illness can make school attendance difficult for many additional reasons.  There are good reasons to keep children home from school – physical illnesses can be contagious, some stages of mental illness are better treated with mental rest, and in some cases of bullying the safest way to deal with an unsafe situation is to remove the child.

Nevertheless, school refusal is avoidance, and anxiety loves avoidance. Nothing is more reinforcing that one cannot handle something than not doing it.  So, after one has checked on physical health and for other explanations, how can professionals support parents to keep their children in school or break the cycle of school avoidance and school refusal?

  1. Help parents identify the behaviors of avoidance and link that to anxiety.

Avoidance is a coping mechanism for dealing with anxiety, which can become maladaptive when avoidance becomes the only options. Avoidance can look a lot of different ways –tantrums, tearfulness, vague physical symptoms, negotiation (more on that later), chaos, and so on.  Parents may not be able to recognize all of the forms avoidance can take. Helping them objectify avoidance will help them strategize on how to deal with it.

  1. We have to truly believe that avoiding school will not make it better.

It can be tempting to collude with anxiety that the precipitant needs to be avoided for all the reasons laid out in this article and we need to be internally convinced that anxiety is not correctly assessing the situation. As difficult as school can be, school occupies a unique place in a child’s life.  It is the place of work, play, and love.  Learning and playing are the main jobs of childhood.  Playing looks both like playing at recess and like experimenting in relationships with both friendship and love. Identity is formed and reformed through our work, play, and love.  When a child is not in school for an extended length of time, they are abrupting their opportunity for this developmental process to proceed.

  1. Negotiation is another way of avoiding and is a dangerous game.

Many of my patients have used a variety of negotiating tactics with their parent: “Let me go in later and then I’ll go, I promise” or “Let me catch up on my work today and I’ll go in tomorrow”. Small avoidances add up to large avoidance and are not moving towards your goal.  Reverse the negotiation and set up conditions that will allow an out as long one starts the day at school.  Often, once anxiety has lost its argument that one cannot handle going to school, staying in school through the day is easier to manage.

  1. Encourage parents to work with the school

Parents and school are on the same side of this concern – both parties want the child to be successful in school. For parents, this may be the first time dealing with school refusal, but it is most certainly not the first time the school has dealt with school refusal.  Most schools have a variety of plans to help keep a child in school.  Have parents reach out to the school and let them know what is going on.

  1. Set small goals that lead to the victory

The ultimate goal of full school participation is an overwhelming prospect. Depending on how severe the school refusal is, reintroducing school can be an extended process of gradually introducing larger and larger challenges.  Perhaps, on the first day, one can only walk through the school doors.  Maybe a student will be able to be in the school building, but not in classes.  Parents can engage trusted friends to provide motivation and encouragement through social interaction and distraction while at school.

  1. School has many different forms

Many families choose alternative school arrangements including home schooling, virtual schooling, and others, for a variety of reasons and this article is not meant to convict choices that do not have a child in a classroom every day. There are many viable options for school that provide an environment that promote healthy development.  When a family is making a decision to change the way school is delivered, help them examine what factors are involved in their decision.  If they are making the decision from a place of believing that the anxiety that drives school avoidance cannot be defeated then, help them with all the ways described above.

School is a venerable and sometimes dreaded rite of passage. A great deal rides on academic and social success in school which increases anxiety and can lead to school refusal.  As a team, parents, professionals, and schools can help keep children and adolescents in school and accomplishing their goals.

The Research Institute at Lindner Center of HOPE is a site for an open label study with the primary goal of validating a signature (model) based on a panel of serum proteomic markers that discriminate Bipolar I, Bipolar II and Major Depression in people seeking treatment for a major depressive episode. The success of this study could lead to the first diagnostic test that would distinguish between the three mood disorders in a person experiencing depressive symptoms.

Lindner Center of HOPE is seeking a total of 90 study participants, between the ages of 18 and 70, with bipolar I depression, bipolar II depression, or major depression, who are currently depressed. Some exclusions apply, so participants should complete a phone screening.

The study duration is 8 weeks and includes 6 visits and 3 blood draws. Subjects will be paid per visit up to a total of $350.

Call 513-536-0707 for more information. All inquiries are kept confidential.

On October 28, 2015, Dr. Elizabeth Wassenaar, Lindner Center of HOPE Psychiatrist and Williams House Medical Director, joined Lon Woodbury on the Woodbury Report radio show.  Their discussion focused on outlining the benefits of a residential assessment for mental health concerns in adolescents.

Click here to listen.

Chris J. Tuell, EdD, LPCC-S, LICDC, Lindner Center of HOPE, Clinical Director of Addiction Services; University of Cincinnati, Department of Counseling, Adjunct Professor, Addiction Studies

 

For many of us growing-up in school, February was all about the Presidents, most notably, Abraham Lincoln. As our opinion of politicians has waned over the years, we can only wish that our political choices were of the caliber of our 16th President. Though the history books play a significant role in our perception and understanding of the “rail-splitter” from Illinois, it often becomes easy for us to forget that Abraham Lincoln was very human. Lincoln led this nation through its worst crisis, while at the same time battled his own internal war of chronic depression.

At the age of 32, Lincoln writes, “I am now the most miserable man living. If what I feel were equally distributed to the whole human family, there would not be one cheerful face on earth. Whether I shall ever better, I cannot tell; I awfully forebode I shall not; to remain as I am is impossible.”

Within the past few years, recent books and articles have addressed Lincoln’s melancholy by examining his own letters and the recorded observations of those who knew him. Lincoln scholars have clear evidence that he suffered from depressive episodes beginning in his twenties and lasting throughout the rest of his life. Lincoln’s school teacher, Mentor Graham stated, “Lincoln told me that he felt like committing suicide often.” Law partner and biographer, William Herndon, stated, “He was a sad looking man, gloomy, and melancholic.” Herndon adds, “His melancholy dripped from him as he walked.”

Depressive disorders affect approximately 18.8 million American adults or about 9.5% of the U.S. population age 18 and older in a given year, according to the National Institute on Mental Health. Depressive disorders may include: Major Depressive Disorder, Dysthymia (an ongoing, low grade depression), and Bipolar Disorder (mood swings of depression and mania). Depression can affect every aspect of one’s life: physical health, sleep, eating habits, job, and your relationships with friends and family. It affects thoughts, feelings and behaviors.

Lincoln was a man with human strengths and frailties.   His depression or melancholy did not define who he was as a person, nor can the same be said for the millions of individuals who suffer from depression every day. Depression is one of the most common and most serious mental health issues facing people today. It is also one of the most treatable.

Lincoln had much cause for sadness throughout his life. His only brother died in infancy. His mother, an aunt, and uncle died from an epidemic when he was nine years of age. Ten years later his sister died giving birth to a stillborn infant. Historical records indicate that Lincoln’s mother and father were disposed to melancholy and that one side of the family “was thick with mental disease.” According to mental health professionals, bereavement in childhood can be one of the most significant factors in the development of depressive illness in later life.

As an adult, Lincoln experienced the loss of a close friend, Ann Rutledge, of whom who he grew fond of while living in New Salem, Illinois in 1835. As a father, Lincoln experienced the death of two young sons, Eddie and Willie. As Commander-in-Chief, one can only imagine the emotional toll the Civil War had upon Lincoln and the 680,088 lives that were lost in its cause.

Before the age of psychotherapy and medication, Lincoln learned to live with his depressive disposition. He would frequently utilize humor and story-telling to elevate his mood and distract himself from his depression. Only his closest friends had any insight concerning the extent of his condition. Learning how to manage his life with his depression was his only choice. The only other option would have been for him to succumb to these adversities. It does not appear that it was in the 16th President’s persona to acquiesce. Lincoln persevered and served this country eloquently.

We can only speculate what Lincoln would say or do about our current state of political affairs, or even what thoughts he may have towards the new millennium’s understanding of depression and mental health. But now, some 150 years later, Lincoln’s historical persona continues to “belong to the ages.” Abraham Lincoln believed in the human spirit and spoke of the role we must all serve toward one another. This was no more clearly expressed than through Lincoln’s own words, “With malice toward none; with charity for all.”

Lindner Center of HOPE’s Chief Research Officer, Dr. Susan McElroy, was recently cited in a Forbes article about her work in the investigation of an experimental drug that could be used in the treatment of depression.

Naurex, a private company founded by a Northwestern University professor in Evanston, Ill., is reporting that this experimental drug works to help push patients out of a major depressive state within 24 hours of getting a single intravenous shot.

Click here to read the Forbes article.

REELABILITIES LOGO with hashtag

Festival Runs February 27th – March 7th, 2015

ReelAbilities is the largest national film festival dedicated to celebrating the lives, stories and art of people with disabilities.

Lindner Center of HOPE is proud to be a part of the 2015 ReelAbilities Film Festival organized by Living Arrangements for the Developmentally Disabled (LADD) which runs February 27th through March 7th 2015 in Greater Cincinnati. For the first year, ReelAbilities is including films touching on the subject of mental illness in the festival. For more information about the film festival, click here.

Lindner Center of HOPE is the Host Agency for HERE ONE DAY, a documentary that chronicles filmmaker Kathy Leichter’s move back into her childhood home after her mother’s suicide. The film will be shown at Kenwood Theater on Monday, March 2, 2015 at 7:30 p.m.

Leichter discovered a hidden box of audiotapes. Sixteen years passed before she had the courage to delve into this trove, unearthing details that her mother had kept secret for so long. HERE ONE DAY is a visually arresting, emotionally candid film about a woman coping with mental illness, her relationships with her family, and the ripple effects of her suicide on those she loved. Click here to view trailer.

Following the film, Lindner Center of HOPE will host a brief panel discussion with question and answers with the audience. Jessica Noll, WCPO, will emcee the discussion.

Panel members will include:

Kathy Leichter, HERE ONE DAY filmmaker

John M. Hawkins, MD, Lindner Center of HOPE, Chief of Psychiatry, Deputy Chief Research Officer, Director TMS Services, University of Cincinnati College of Medicine, Adjunct Associate Clinical Professor of Psychiatry

Charles F. Brady, PhD, ABPP, Lindner Center of HOPE, Staff Psychologist, OCD/CBT Psychotherapist, Professor the University of Cincinnati’s Department of Psychiatry

Angela Ostholthoff, CPRP, CPS, Training Coordinator for The Recovery Center of Hamilton County

Shirley Benoit, Patient/Advocate

Here One Day imageHERE ONE DAY

Kathy Leichter / USA / English / 2012 /

76 min. / Documentary / Open Captions

Monday

March 2nd, 2015 – 7:30pm

at the Kenwood Theater

Benefiting the Lindner Center of HOPE,  Buy Tickets Here.

Paul Keck image smallMason, OH, November 19, 2014 – Lindner Center of HOPE’s President and CEO, Dr. Paul E. Keck, Jr., was named amongst Thomson Reuters Highly Cited Researchers, a listing of the world’s leading scholars in the sciences and social sciences, in honor of his landmark contributions to research in the field of Psychiatry/Psychology.

Thomson Reuters, evaluates and recognizes excellence in the scholarly community as demonstrated by the quantitative impact of the sciences by consistently monitoring the undeniable link between citations and influence. Dr. Keck was selected as a Highly Cited Researcher due to the number of citations his work has received from fellow researchers. Essentially, his peers have identified his contributions as being among the most valuable and significant in the field of Psychiatry/Psychology.

The global nature of this study highlights the researchers, institutions and countries on the cutting edge of science, those who are developing innovations that will lead to a brighter tomorrow. The listing of the Highly Cited Researchers was compiled by assessing papers indexed within the Web of Science™ between 2002 and 2012 in 21 broad fields of study. Analysts tracked authors who published numerous articles ranking among the top one percent of the most cited in their respective fields in a given year of publication. View the list and methodology at highlycited.com.

Dr. Keck was also listed in The World’s Most Influential Scientific Minds: 2014. This report is at ScienceWatch.com.

Lindner Center of HOPE provides excellent, patient-centered, scientifically-advanced care for individuals suffering with mental illness. A state-of-the-science, mental health center and charter member of the National Network of Depression Centers, the Center provides psychiatric hospitalization and partial hospitalization for individuals age 12-years-old and older, outpatient services for all ages, diagnostic and short-term residential services for adults and adolescents, intensive outpatient program for substance abuse and co-occurring disorders for adults and research. The Center is enhanced by its partnership with UC Health as its clinicians are ranked among the best providers locally, nationally and internationally. Together Lindner Center of HOPE and UC Health offer a true system of mental health care in the Greater Cincinnati area and across the country. The Center is also affiliated with the University of Cincinnati (UC) College of Medicine.